Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Michael J Hansbury"'
Autor:
Aidan G. Gilmartin, James D. Winkler, Michael J Hansbury, A. Colombo, Jeffrey R. Jackson, Paola Zaratin, Boyd B Scott, C. Belpasso
Publikováno v:
Biochemical and Biophysical Research Communications. 328:409-414
Angiopoietin-1 (Ang-1) is one of a family of ligands for the Tie-2 receptor which has been demonstrated to be involved in angiogenesis. Little is known about the regulation of Ang-1 gene expression. We have previously demonstrated that TNF-alpha is a
Autor:
Beverly A Tinkelenberg, Sal Caradonna, Michael J Hansbury, Robert D. Ladner, Imane Elateri, Susan Muller-Weeks
Publikováno v:
DNA Repair. 2:315-323
There are at least four distinct families of enzymes that recognize and remove uracil from DNA. Family-3 (SMUG1) enzymes have recently been identified and have a preference for uracil in single-stranded DNA when assayed in vitro. Here we investigate
Publikováno v:
Angiogenesis. 4:29-36
The Tie2 receptor and its known ligands, the angiopoietins, play a critical role in endothelial cell differentiation during the process of angiogenesis. Recent experimental observations indicate that the agonistic ligand, angiopoietin-1, can stimulat
Autor:
Lisa A. Marshall, Michael J. Hansbury, Brian J. Bolognese, Rebecca J. Gum, Peter R. Young, Ruth J. Mayer
Publikováno v:
The Journal of Immunology. 161:6005-6013
CD23, the low affinity IgE receptor, is up-regulated on the surface of IL-4-treated B cells and monocytes and is immediately proteolytically processed, releasing soluble fragments of CD23. Here, we report that inhibitors of the p38 mitogen-activated
Autor:
Kevin Moulder, Lisa Marshall, Gregory P. Harper, Ruth J. Mayer, Michael J. Hansbury, Vivienne M. Spackman, Gary Christie, Brian Bolognese, Derek R. Buckle, Sheila M. Seal, Aisling Barton, Mark McCord, Richard M. Cook, Paul R. Murdock, Beverley Jane Weston
Publikováno v:
European Journal of Immunology. 27:3228-3235
CD23, the low-affinity IgE receptor, is up-regulated on interleukin (IL)-4-stimulated B cells and monocytes, with a concomitant increase in the release of soluble fragments of CD23 (sCD23) into the medium by proteolytic processing of the surface-boun
Autor:
Susan J. Muller, Mary C. Kosciuk, Robert D. Ladner, Frank Lynch, Sal Caradonna, Michael J Hansbury
Publikováno v:
Experimental Cell Research. 222:345-359
Evidence is presented on two forms of uracil-DNA glycosylase (UDG1 and UDG2) that exist in human cells. We have developed an affinity technique to isolate uracil-DNA glycosylases from HeLa cells. This technique relies on the use of a uracil-DNA glyco
Publikováno v:
Biochemical and Biophysical Research Communications. 171:525-530
Molecular analysis of the induction of the lutropin/choriogonadotropin receptor during the process of luteinization of the rat ovary was performed. The appearance of receptor binding activity and an immunological analysis of the receptor using Triton
Autor:
Scott K. Thompson, Randall K. Johnson, Thau F. Ho, Keith W. Ward, Lara S. Kallander, Thaddeus A. Tomaszek, Cheryl A. Janson, Kyung O. Johanson, Robert B. Kirkpatrick, Ward W. Smith, Guang Yang, Michael R. Mattern, Gui-Feng Zhang, Christina K. Schulz-Pritchard, Michael J Hansbury, Ryan M Dominic, Wenfang Chen, James D. Winkler, Thomas D. Meek, Daniel F. Veber, David G. Tew, Qing Lu, P.W. Fisher, Glenn A. Hofmann
Publikováno v:
Journal of medicinal chemistry. 48(18)
Inhibitors of human methionine aminopeptidase type 2 (hMetAP2) are of interest as potential treatments for cancer. A new class of small molecule reversible inhibitors of hMetAP2 was discovered and optimized, the 4-aryl-1,2,3-triazoles. Compound 24, a
Publikováno v:
Cancer research. 62(17)
The thymidylate synthase reaction remains an important target for widely used anticancer agents; however, the clinical utility of these drugs is limited by the occurrence of cellular resistance. Despite the considerable amount of information availabl
Autor:
Boyd B, Scott, Paola F, Zaratin, Antonio, Colombo, Michael J, Hansbury, James D, Winkler, Jeffrey R, Jackson
Publikováno v:
The Journal of rheumatology. 29(2)
Angiopoietin- I (Ang-1) and Ang-2 are ligands for the receptor tyrosine kinase, Tie-2. Ang-1, a Tie-2 agonist, may have a vascular stabilizing role in angiogenesis, while Ang-2, an endogenous antagonist of Tie-2, may have an early role in angiogenesi